These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 22923733)
1. Mediator lipidomics in acute inflammation and resolution. Arita M J Biochem; 2012 Oct; 152(4):313-9. PubMed ID: 22923733 [TBL] [Abstract][Full Text] [Related]
2. Eosinophil polyunsaturated fatty acid metabolism and its potential control of inflammation and allergy. Arita M Allergol Int; 2016 Sep; 65 Suppl():S2-5. PubMed ID: 27371965 [TBL] [Abstract][Full Text] [Related]
3. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Serhan CN Annu Rev Immunol; 2007; 25():101-37. PubMed ID: 17090225 [TBL] [Abstract][Full Text] [Related]
4. Resolvins and protectins in the termination program of acute inflammation. Ariel A; Serhan CN Trends Immunol; 2007 Apr; 28(4):176-83. PubMed ID: 17337246 [TBL] [Abstract][Full Text] [Related]
5. Novel omega -- 3-derived local mediators in anti-inflammation and resolution. Serhan CN Pharmacol Ther; 2005 Jan; 105(1):7-21. PubMed ID: 15626453 [TBL] [Abstract][Full Text] [Related]
6. Emerging roles of eosinophils and eosinophil-derived lipid mediators in the resolution of inflammation. Isobe Y; Kato T; Arita M Front Immunol; 2012; 3():270. PubMed ID: 22973272 [TBL] [Abstract][Full Text] [Related]
7. Mediator lipidomics: search algorithms for eicosanoids, resolvins, and protectins. Serhan CN; Lu Y; Hong S; Yang R Methods Enzymol; 2007; 432():275-317. PubMed ID: 17954222 [TBL] [Abstract][Full Text] [Related]
11. Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators. Serhan CN J Periodontol; 2008 Aug; 79(8 Suppl):1520-6. PubMed ID: 18673006 [TBL] [Abstract][Full Text] [Related]
12. New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases. Yacoubian S; Serhan CN Nat Clin Pract Rheumatol; 2007 Oct; 3(10):570-9; quiz 1 p following 589. PubMed ID: 17906612 [TBL] [Abstract][Full Text] [Related]
13. Chiral lipidomics of E-series resolvins: aspirin and the biosynthesis of novel mediators. Oh SF; Vickery TW; Serhan CN Biochim Biophys Acta; 2011 Nov; 1811(11):737-47. PubMed ID: 21712098 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive quantitative determination of PUFA-related bioactive lipids for functional lipidomics using high-resolution mass spectrometry. Masoodi M; Volmer DA Methods Mol Biol; 2014; 1198():221-32. PubMed ID: 25270932 [TBL] [Abstract][Full Text] [Related]
15. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Serhan CN; Chiang N Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S200-15. PubMed ID: 17965751 [TBL] [Abstract][Full Text] [Related]
16. Lipoxins and new lipid mediators in the resolution of inflammation. Schwab JM; Serhan CN Curr Opin Pharmacol; 2006 Aug; 6(4):414-20. PubMed ID: 16750421 [TBL] [Abstract][Full Text] [Related]
17. Comparative lipidomic analysis of inflammatory mediators in the aqueous humor and tear fluid of humans and rabbits. Chistyakov DV; Azbukina NV; Astakhova AA; Goriainov SV; Chistyakov VV; Tiulina VV; Baksheeva VE; Kotelin VI; Fedoseeva EV; Zamyatnin AA; Philippov PP; Kiseleva OA; Bessmertny AM; Senin II; Iomdina EN; Sergeeva MG; Zernii EY Metabolomics; 2020 Feb; 16(2):27. PubMed ID: 32052201 [TBL] [Abstract][Full Text] [Related]
19. Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Calder PC Biochimie; 2009 Jun; 91(6):791-5. PubMed ID: 19455748 [TBL] [Abstract][Full Text] [Related]
20. Endogenous pro-resolving and anti-inflammatory lipid mediators: the new hope of atherosclerotic diseases. Chen Y; Wang J; Nie R; Zhou S Med Hypotheses; 2008 Aug; 71(2):237-40. PubMed ID: 18448265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]